Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Arena Pharmaceuticals Inc. (ARNA)

62.47   -0.48 (-0.76%) 07-01 16:00
Open: 63.07 Pre. Close: 62.95
High: 63.305 Low: 61.535
Volume: 679,543 Market Cap: 3,540M
Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include ralinepag (APD811), which is in Phase III trial to treat pulmonary arterial hypertension; etrasimod (APD334) for ulcerative colitis, and Crohn's disease, as well as for atopic dermatitis and other indications; and Olorinab (APD371), which is in Phase II trial for the treatment of gastrointestinal pain. It is also developing APD418, a calcium-independent myofilament derepressor for the treatment of decompensated heart failure. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Axovant Sciences GmbH; Outpost Medicine LLC; CY Biotech Company Limited; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 63.403 - 63.723 63.723 - 63.986
Low: 60.798 - 61.133 61.133 - 61.409
Close: 61.975 - 62.505 62.505 - 62.94

Technical analysis

as of: 2020-07-01 4:30:10 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 81.47     One year: 95.15
Support: Support1: 58.56    Support2: 51.64
Resistance: Resistance1: 69.75    Resistance2: 81.47
Pivot: 63.61
Moving Average: MA(5): 63.95     MA(20): 63.84
MA(100): 51.72     MA(250): 51.00
MACD: MACD(12,26): 1.66     Signal(9): 2.30
Stochastic oscillator: %K(14,3): 37.81     %D(3): 51.63
RSI: RSI(14): 51.72
52-week: High: 69.75  Low: 32.95  Change(%): 0.9
Average Vol(K): 3-Month: 79398  10-Days: 77607

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ARNA has closed above bottom band by 29.5%. Bollinger Bands are 52.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to ARNA's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 29 Jun 2020
What's Behind Arena Pharmaceuticals, Inc. (ARNA) Volatile Ride? - The News Heater

Mon, 29 Jun 2020
Arena Pharmaceuticals Inc. (ARNA) is 17.21% away from 50-day simple Moving Average despite all headwinds - News Daemon

Thu, 18 Jun 2020
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - PRNewswire

Wed, 17 Jun 2020
Arena Pharmaceuticals Inc. (ARNA) Soars 1.11% on June 17 - Equities.com

Mon, 15 Jun 2020
Arena Pharmaceuticals Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors - Yahoo Finance

Mon, 08 Jun 2020
Arena Pharmaceuticals Announces R&D Leadership Transition - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 57
Shares Float (M) 50
% Held by Insiders 0.15
% Held by Institutions 84.16
Shares Short (K) 3,910
Shares Short P. Month (K) 4,230

Stock Financials

EPS -6.470
EPS Est This Year -2.940
EPS Est Next Year -2.730
Book Value (p.s.) 19.650
Profit Margin
Operating Margin -6147.57
Return on Assets (ttm) -17.9
Return on Equity (ttm) -28.9
Qtrly Rev. Growth -100.0
Gross Profit (p.s.) 10.147
Sales Per Share 0.100
EBITDA (p.s.) -6.055
Qtrly Earnings Growth
Operating Cash Flow (M) -263
Levered Free Cash Flow (M) -161

Stock Valuations

PE Ratio -9.66
PEG Ratio
Price to Book value 3.18
Price to Sales 627.58
Price to Cash Flow -13.46

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.